Q2 2024 Holdings
Filed 2024-08-14 | 119 holdings | $733.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Teva Pharmaceutical Inds LTD(TEVA)Call | SPONSORED ADS | 881624209 | $53.1M | 3,268,900 | 7.2% |
| Vaneck ETF Trust(SMH)Put | SEMICONDUCTR ETF | 92189F676 | $39.1M | 149,800 | 5.3% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $23.1M | 910,070 | 3.1% |
| Sanofi(SNY) | SPONSORED ADR | 80105N105 | $21.8M | 449,515 | 3.0% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $20.9M | 384,924 | 2.8% |
| Amazon COM Inc(AMZN) | COM | 023135106 | $19.6M | 101,432 | 2.7% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $16.9M | 822,047 | 2.3% |
| Meta Platforms Inc(META) | CL A | 30303M102 | $16.9M | 33,439 | 2.3% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $14.8M | 190,060 | 2.0% |
| Microsoft Corp(MSFT) | COM | 594918104 | $14.7M | 32,927 | 2.0% |
| Nice LTD(NSY) | SPONSORED ADR | 653656108 | $14.0M | 81,461 | 1.9% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $13.2M | 83,659 | 1.8% |
| Apple Inc(AAPL) | COM | 037833100 | $13.0M | 61,500 | 1.8% |
| Teva Pharmaceutical Inds LTD(TEVA) | SPONSORED ADS | 881624209 | $12.8M | 789,416 | 1.7% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $12.6M | 610,826 | 1.7% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $12.1M | 293,832 | 1.6% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $11.9M | 13,190 | 1.6% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $11.7M | 283,424 | 1.6% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $11.4M | 309,265 | 1.6% |
| Novo-Nordisk A S(NVO) | ADR | 670100205 | $11.1M | 78,080 | 1.5% |
| Biogen Inc(BIIB) | COM | 09062X103 | $11.0M | 47,412 | 1.5% |
| Invesco QQQ TR(QQQ)Call | UNIT SER 1 | 46090E103 | $11.0M | 22,900 | 1.5% |
| Skye Bioscience Inc(SKYE) | COM NEW | 83086J200 | $10.4M | 1,298,312 | 1.4% |
| Jasper Therapeutics Inc(JSPR) | COM NEW | 471871202 | $10.3M | 454,227 | 1.4% |
| Johnson & Johnson(JNJ) | COM | 478160104 | $10.2M | 69,831 | 1.4% |
| Asml Holding N V(ASML) | N Y REGISTRY SHS | N07059210 | $10.1M | 9,901 | 1.4% |
| Merus N V | COM | N5749R100 | $8.7M | 147,633 | 1.2% |
| Salesforce Inc(CRM) | COM | 79466L302 | $8.6M | 33,600 | 1.2% |
| Immatics N.v(IMTX) | SHS | N44445109 | $8.5M | 731,111 | 1.2% |
| Perspective Therapeutics Inc(CATX) | COM NEW | 46489V302 | $7.8M | 786,909 | 1.1% |
| Pharvaris N V(PHVS) | COM | N69605108 | $7.6M | 403,265 | 1.0% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $7.4M | 59,600 | 1.0% |
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $7.3M | 1,707,999 | 1.0% |
| Cybin Inc(CYBNEUR) | COM | 23256X100 | $6.9M | 25,581,395 | 0.9% |
| Vigil Neuroscience Inc(VIGL) | COM | 92673K108 | $6.8M | 1,692,166 | 0.9% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $6.7M | 140,238 | 0.9% |
| Inozyme Pharma Inc | COM | 45790W108 | $6.5M | 1,462,724 | 0.9% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $6.5M | 38,000 | 0.9% |
| Palo Alto Networks Inc(PANW) | COM | 697435105 | $6.1M | 18,000 | 0.8% |
| Sentinelone Inc(S) | CL A | 81730H109 | $6.0M | 283,804 | 0.8% |
| Tower Semiconductor LTD(TSEM) | SHS NEW | M87915274 | $5.9M | 149,600 | 0.8% |
| Applied Matls Inc(AMAT) | COM | 038222105 | $5.8M | 24,604 | 0.8% |
| Enphase Energy Inc(ENPH) | COM | 29355A107 | $5.7M | 56,792 | 0.8% |
| Nice LTD(NSY)Call | SPONSORED ADR | 653656108 | $5.5M | 32,100 | 0.8% |
| Novartis AG(NVSN) | SPONSORED ADR | 66987V109 | $5.3M | 50,000 | 0.7% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $5.3M | 327,539 | 0.7% |
| Bridgebio Pharma Inc(BBIO)Call | COM | 10806X102 | $5.2M | 204,600 | 0.7% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $5.2M | 442,752 | 0.7% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $5.1M | 242,526 | 0.7% |
| Micron Technology Inc(MU) | COM | 595112103 | $4.9M | 37,000 | 0.7% |